Literature DB >> 4802501

Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation.

S R Mostow, S C Schoenbaum, W R Dowdle, M T Coleman, H S Kaye.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4802501      PMCID： PMC2495385          DOI： 10.1136/pgmj.49.569.152

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  4 in total

1.  Purified influenza virus vaccine. A study of viral reactivity and antigenicity.

Authors:  F B Peck
Journal:  JAMA       Date:  1968-12-02       Impact factor: 56.272

2.  Purification of large quantities of influenza virus by density gradient centrifugation.

Authors:  C B Reimer; R S Baker; R M Van Frank; T E Newlin; G B Cline; N G Anderson
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

3.  Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man.

Authors:  S R Mostow; S C Schoenbaum; W R Dowdle; M T Coleman; H S Kaye; J C Hierholzer
Journal:  Am J Epidemiol       Date:  1970-10       Impact factor: 4.897

4.  Studies on inactivated influenza vaccines. I. The effect of dosage on antibody response and protection against homotypic and heterotypic influenza virus challenge in mice.

Authors:  H S Kaye; W R Dowdle; J L McQueen
Journal:  Am J Epidemiol       Date:  1969-08       Impact factor: 4.897
  4 in total
  7 in total

Review 1.  Inactivated influenza vaccines: recent progress and implications for the elderly.

Authors:  Valentina Parodi; Daniela de Florentiis; Mariano Martini; Filippo Ansaldi
Journal:  Drugs Aging       Date:  2011-02-01       Impact factor: 3.923

Review 2.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

3.  The response to inactivated influenza A (H3N2) vaccines: the development and effect of antibodies to the surface antigens.

Authors:  A F Smith; J R Davies
Journal:  J Hyg (Lond)       Date:  1977-06

4.  Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.

Authors:  Wilbur H Chen; Alan S Cross; Robert Edelman; Marcelo B Sztein; William C Blackwelder; Marcela F Pasetti
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

5.  The imperative of influenza vaccines for elderly individuals-an evolving story.

Authors:  Gregory A Poland; Mark J Mulligan
Journal:  J Infect Dis       Date:  2009-07-15       Impact factor: 5.226

Review 6.  Systems vaccinology.

Authors:  Bali Pulendran; Shuzhao Li; Helder I Nakaya
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

Review 7.  Influenza vaccination in cancer patients undergoing systemic therapy.

Authors:  Mahmoud A Shehata; Nagla Abdel Karim
Journal:  Clin Med Insights Oncol       Date:  2014-05-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.